Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Sexual Harassment Scandals Hit Novartis and Pfizer's Korea Units

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

On Wednesday, KBR reported that a male employee at Novartis Korea reported to the company that his female boss sexually harassed him in September. Source: BioSpace

Continue ReadingSexual Harassment Scandals Hit Novartis and Pfizer's Korea Units

3 Bioeconomy Stocks Investors Should Not Hesitate to Buy

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

While the words biotech and biopharma are often used interchangeably, they aren't the same thing - not even close, in fact. Source: BioSpace

Continue Reading3 Bioeconomy Stocks Investors Should Not Hesitate to Buy

Why This Overlooked Seattle Drugmaker Could be the Best Biotech Buy Right Now

  • Post author:Sam
  • Post published:November 28, 2017
  • Post category:BioPharma

Omeros is getting a lot of love from investors and analysts these days. Source: BioSpace

Continue ReadingWhy This Overlooked Seattle Drugmaker Could be the Best Biotech Buy Right Now

Meet the Scientist Who Admits His MS Therapy is 'Largely Ineffective.'

  • Post author:Sam
  • Post published:November 28, 2017
  • Post category:BioPharma

What many hope will be the final chapter in an unfortunate saga in multiple sclerosis research appears to have been written by the scientist who started the affair in the…

Continue ReadingMeet the Scientist Who Admits His MS Therapy is 'Largely Ineffective.'

Why This Small SoCal Biotech's Pipeline Makes it Flushed for Growth

  • Post author:Sam
  • Post published:November 28, 2017
  • Post category:BioPharma

Nobody is interested in slow-growth or no-growth stocks, long term or short term, but everyone's interested in fast-growing stocks. Source: BioSpace

Continue ReadingWhy This Small SoCal Biotech's Pipeline Makes it Flushed for Growth

Regeneron Forges Out-of-the-Box R&D Pact With Boston's Decibel Therapeutics

  • Post author:Sam
  • Post published:November 28, 2017
  • Post category:BioPharma

Regeneron and Decibel scientists will be working together, shoulder to shoulder, on project teams beginning at the earliest stages of research. Source: BioSpace

Continue ReadingRegeneron Forges Out-of-the-Box R&D Pact With Boston's Decibel Therapeutics

ITUS Pushes CAR-T Program for Solid Tumors, Develops Early Cancer Detection Platform

  • Post author:Sam
  • Post published:November 28, 2017
  • Post category:BioPharma

Tiny ITUS believes it is on track to develop a CAR-T treatment for solid tumors. Source: BioSpace

Continue ReadingITUS Pushes CAR-T Program for Solid Tumors, Develops Early Cancer Detection Platform

Frazier-Backed Mavupharma Scores $20M to Fund STING Program

  • Post author:Sam
  • Post published:November 28, 2017
  • Post category:BioPharma

The Series A funding will be used primarily to advance Mavu's lead drug candidates into the clinic. Source: BioSpace

Continue ReadingFrazier-Backed Mavupharma Scores $20M to Fund STING Program

Alkermes Allegedly Fired 3 Female Employees Who Raised Concerns of Bias

  • Post author:Sam
  • Post published:November 28, 2017
  • Post category:BioPharma

After being criticized earlier this month by U.S. Sen. Kamala Harris, three separate sexual harassment lawsuits have been reported. Source: BioSpace

Continue ReadingAlkermes Allegedly Fired 3 Female Employees Who Raised Concerns of Bias

Boston Scientific Loses $3B on Latest Lotus Valve Delay

  • Post author:Sam
  • Post published:November 28, 2017
  • Post category:BioPharma

A delay in returning its Lotus Edge Aortic Valve System to the market has cost Boston Scientific an estimated $3B loss in market capitalization. Source: BioSpace

Continue ReadingBoston Scientific Loses $3B on Latest Lotus Valve Delay
  • Go to the previous page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.